Detection of black market follistatin 344

Research output: Contribution to journalConference article in journalResearchpeer-review

Authors

Research units

Details

Abstract Follistatin, a myostatin-inhibiting protein, is prohibited according to chapter S4 of the “WADA 2019 List of Prohibited Substances and Methods”. While currently no approved pharmaceutical formulations of follistatin are available, follistatin can be bought on the black market. Most of the products are labeled “follistatin 344” (FS344), a few “follistatin 315”. A study on FS344 black market products was performed and an electrophoretic detection method for serum and urine developed. While only nine of the 17 tested products actually contained follistatin, in some of the others growth promoting peptides were found (e.g. MGF, GHRP-2). Surprisingly, all nine products contained His-tagged FS344 and a high degree of its oligomers. The detection method is based on immunomagnetic purification followed by SDS-PAGE and Western blotting with a monoclonal anti-His antibody. Alternatively, a monoclonal anti-follistatin antibody can be used. For immunoprecipitation (IP), a polyclonal anti-follistatin antibody is applied. An evaluation of suitable antibodies for IP and immunoblotting is also presented. Furthermore, practically all currently available follistatin standards were investigated. The detection limit of the method for black market FS344 in urine is ca 0.1 ng/mL for 10 mL. For a sample volume of 100 μL, an LOD of 5 ng/mL could be achieved for serum. Due to the presence of His-tags an unambiguous differentiation from endogenous follistatin is possible.
Original languageEnglish
JournalDrug testing and analysis
Volume11
Issue number11-12
Pages (from-to)1675-1697
Number of pages23
ISSN1942-7603
DOIs
Publication statusPublished - 01.11.2019
EventManfred Donike Workshop on Doping Analysis - Cologne, Germany
Duration: 17.02.201922.02.2019
Conference number: 37

ID: 5183534

View graph of relations